Symposia: Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Research, Adult, Clinical trials, Clinical Practice (Health Services and Quality), Epidemiology, Clinical Research, Genomics, Hemoglobinopathies, Pediatric, Diseases, Treatment Considerations, Real-world evidence, Young adult , Registries, Biological Processes, Survivorship, Technology and Procedures, Study Population, Human, Multi-systemic interactions, Pathogenesis, Imaging
Type: Oral
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Research, Adult, Clinical trials, Clinical Practice (Health Services and Quality), Epidemiology, Clinical Research, Genomics, Hemoglobinopathies, Pediatric, Diseases, Treatment Considerations, Real-world evidence, Young adult , Registries, Biological Processes, Survivorship, Technology and Procedures, Study Population, Human, Multi-systemic interactions, Pathogenesis, Imaging
Monday, December 9, 2024: 2:45 PM-4:15 PM
Room 33
(San Diego Convention Center)
Moderators:
Susanna Curtis, MD, PhD, Yale University
and
Evangelia Vlachodimtropoulou Koumoutsea, MBBS, PhD, BSc, King's College Hospital
Disclosures:
Curtis: Pfizer: Honoraria.
You may think you already know all about organ injury in this disease. In this session, there are new discoveries on genetic markers and how the organ injury is different from the typical age-related damage.
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH